People | September 05, 2024
Akums appoints Shantanu R Chobhe as Corporate Quality Assurance Head
Chobhe brings over 30 years of extensive experience in quality and regulatory management within the pharmaceutical industry
Chobhe brings over 30 years of extensive experience in quality and regulatory management within the pharmaceutical industry
TTP Group is a leading engineering firm specializing in biotech and pharmaceutical industry
Vonoprazan is used in the treatment of disorders related to Gastroesophageal Reflux Disease (GERD)
The new facility further improves the operational efficiency and readies the site for the completion of the new large-scale production plant
Finerenone is the first mineralocorticoid receptor (MR) antagonist to demonstrate definitive cardiovascular benefits in a Phase III study in patients with heart failure (HF) with a left ventricular ejection fraction (LVEF) of ?40%
The company is making its mark through strategic initiatives, promising to become a significant presence in the evolving pharmaceutical sector
First-in-human Phase-1 study will evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of SUVN-I6107 in healthy subjects
First patient enrolled in the Phase III SOHO-02 trial of investigational agent BAY 2927088 in treatment-naïve patients with advanced NSCLC with HER2-activating mutations
Ordspono is Regeneron’s first approved bispecific antibody and will provide an off-the-shelf option that can be administered in the out-patient setting, with hope for complete remission
Bortezomib Injection is approved for subcutaneous or intravenous use. It is available as a single dose vial of 3.5 mg/1.4 mL (2.5 mg/mL)
Subscribe To Our Newsletter & Stay Updated
